Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141362 |
| CAS No | NA |
| Mol.F. | C22H19F3N2O |
| Mol.Wt. | 384.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141363 |
| CAS No | NA |
| Mol.F. | C22H19F3N2O |
| Mol.Wt. | 384.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141364 |
| CAS No | NA |
| Mol.F. | C26H27N5O4 |
| Mol.Wt. | 473.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141365 |
| CAS No | NA |
| Mol.F. | C20H26N2O2 |
| Mol.Wt. | 326.44 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141366 |
| CAS No | 2680528-95-2 |
| Mol.F. | C19H24N2O2 |
| Mol.Wt. | 312.41 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141368 |
| CAS No | NA |
| Mol.F. | C8H22N6O |
| Mol.Wt. | 218.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141369 |
| CAS No | NA |
| Mol.F. | C8H21N7O2 |
| Mol.Wt. | 247.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141370 |
| CAS No | NA |
| Mol.F. | C8H21N7O2 |
| Mol.Wt. | 247.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141371 |
| CAS No | NA |
| Mol.F. | C8H20N8O3 |
| Mol.Wt. | 276.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141372 |
| CAS No | NA |
| Mol.F. | C13H17Br2N3O2 |
| Mol.Wt. | 407.1 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141373 |
| CAS No | NA |
| Mol.F. | C9H8Cl2N4O |
| Mol.Wt. | 259.1 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141374 |
| CAS No | NA |
| Mol.F. | C5H7N3O3 |
| Mol.Wt. | 157.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141375 |
| CAS No | NA |
| Mol.F. | C11H10Cl2N4O2 |
| Mol.Wt. | 301.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141376 |
| CAS No | NA |
| Mol.F. | C18H18Cl2N2O5 |
| Mol.Wt. | 413.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141377 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O5 |
| Mol.Wt. | 399.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141378 |
| CAS No | NA |
| Mol.F. | C19H20Cl2N2O5 |
| Mol.Wt. | 427.3 |
| INV STATUS | CUSTOM SYNTHESIS |